HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Keymed Biosciences - Challenges Are Inevitable Despite Some Advantages on Pipeline

Pre-IPO Suzhou NanoMicro Tech - A Good Company You Don't Want to Miss

Pre-IPO Broncus Holding Corporation - The Strength and the Concerns

Modern Dental Group (3600.HK) - Insights on Recent Rally of Stock Price and Future Outlook

Pre-IPO Zylox-Tonbridge Medical Technology - Promising Market with Challenges

Pre-IPO We Doctor Holdings - Here Are the Concerns

Gravity Works As WeWork Doesn't; Now Plan B

Bifurcated Chinese Express Market Developing

Equity Capital Markets

Shanghai Conant Optical / Equity Capital Markets

<p>On April 1, 2021, <a href="https://www.smartkarma.com/entities/shanghai-conant-optical-co-ltd" target="_blank" data-smartkarma-citation="entities:33004:1" rel="noopener">Shanghai Conant Optical (SCO CH)</a> submitted its IPO prospectus to the Hong Kong Stock Exchange. Actually, <a href="https://www.smartkarma.com/entities/shanghai-conant-optics-co-a" target="_blank" data-smartkarma-citation="entities:8902:1" rel="noopener">Shanghai Conant Optics Co A (300061 CH)</a> became listed in the Shenzhen Stock Exchange in March 2010. At the time of listing, the Company enjoyed high reputation as the leading resin spectacle lens manufacturer in China and also had wide business exposure in the global market. However, after becoming a public company, the net profit attributed to shareholders of Conant Optical was RMB16 million in 2010 (down 25% YoY), RMB9.56 million in 2011 (down 40% YoY) and RMB(-840,000) in 2012 (down 109% YoY), decreasing for three consecutive years. So, how about Conant Optical after more than a decade? The following mainly analyzed the strength and concerns for the Company.</p>

On April 1, 2021, Shanghai Conant Optical (SCO CH) submitted its IPO prospectus to the Hong Kong Stock Exchange. Actually, Shanghai Conant Optics Co A (300061 CH) became listed in the Shenzhen Stock Exchange in March 2010. At the time of listing, the Company enjoyed high reputation as the leading resin spectacle lens manufacturer in China and also had wide business exposure in the global market. However, after becoming a public company, the net profit attributed to shareholders of Conant Optical was RMB16 million in 2010 (down 25% YoY), RMB9.56 million in 2011 (down 40% YoY) and RMB(-840,000) in 2012 (down 109% YoY), decreasing for three consecutive years. So, how about Conant Optical after more than a decade? The following mainly analyzed the strength and concerns for the Company.

Pre-IPO Shanghai Conant Optical - Here Are the Strength and the Concerns